Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Marisella Panduro

2PUBLICATIONS
17CO-AUTHORS
Tumour immunologyHuman impacts of climate change and human adaptation
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

Sort by Publication Date:
|Dec 21, 2025
CHS-114: An Afucosylated Anti-CCR8 Monoclonal Antibody that Selectively Depletes Intratumoral Treg Cells and Induces Antitumor Immune Responses.

Xiaoguang Wang, Varun N Kapoor, Daniel J Chin

|May 23, 2023
SRF617 Is a Potent Inhibitor of CD39 with Immunomodulatory and Antitumor Properties.

Michael C Warren, Stephan Matissek, Matthew Rausch

Pageof 1

Frequent Collaborators

1 joint publications

Matthew Rausch

1 joint publications

Yu Yang

1 joint publications

Célia Jacoberger Foissac

1 joint publications

John Stagg

1 joint publications

Xiaoguang Wang

1 joint publications

Varun N Kapoor

1 joint publications

Daniel J Chin

1 joint publications

Scott L Klakamp

1 joint publications

Federico Baruffaldi

1 joint publications

James F Mohan

Frequent Collaborators

1 joint publications

Matthew Rausch

1 joint publications

Yu Yang

1 joint publications

Célia Jacoberger Foissac

1 joint publications

John Stagg

Top Related Videos

Assessment of Human Natural Killer Cell Events Driven by FcγRIIIa Engagement in the Presence of Therapeutic Antibodies
09:54

Assessment of Human Natural Killer Cell Events Driven by FcγRIIIa Engagement in the Presence of Therapeutic Antibodies

Published on : May 22, 2020

3.8K
A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells
08:46

A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells

Published on : Nov 12, 2019

53.4K
See more related videos

Top Related Videos

Assessment of Human Natural Killer Cell Events Driven by FcγRIIIa Engagement in the Presence of Therapeutic Antibodies
09:54

Assessment of Human Natural Killer Cell Events Driven by FcγRIIIa Engagement in the Presence of Therapeutic Antibodies

Published on : May 22, 2020

3.8K
A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells
08:46

A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells

Published on : Nov 12, 2019

53.4K
See more related videos